Resection of hepatic metastases is indicated in selected stage IV colorectal cancer (CRC) patients. A minority will eventually develop pulmonary metastases and may undergo lung surgery with curative intent. The aims of the present study were to assess clinical outcome and identify parameters predicting survival after pulmonary metastasectomy in patients who underwent prior resection of hepatic CRC metastases
Surgery is considered an effective therapeutic option for patients with lung metastasis (MTS) of col...
To assess the impact of a history of liver metastases on survival in patients undergoing surgery for...
Aim: Lung and liver are the most common sites of metastases from colorectal cancer (CRC), and approx...
Background: Resection of hepatic metastases is indicated in selected stage IV colorectal cancer (CRC...
BACKGROUND: Resection of hepatic metastases is indicated in selected stage IV colorectal cancer (CRC...
BACKGROUND: Few patients with lung metastases from colorectal cancer (CRC) are candidates for surgic...
40–50% of patients with colorectal cancer (CRC) will develop liver metastases (CRLM) during the cour...
BACKGROUND:40-50% of patients with colorectal cancer (CRC) will develop liver metastases (CRLM) duri...
BACKGROUND: Data addressing the outcomes and patterns of recurrence after pulmonary metastasectomy (...
Colorectal cancer (CRC) is a frequently occurring disease, yet diagnosed at a local stage in only 40...
Data addressing the outcomes and patterns of recurrence after pulmonary metastasectomy (PM) in patie...
Resection of lung metastases (LM) from colorectal cancer (CRC) is increasingly performed with a cura...
ObjectiveOur objective was to investigate the role of clinicopathologic factors as predictors of out...
BACKGROUND: Resection of lung metastases (LM) from colorectal cancer (CRC) is increasingly performed...
Liver and pulmonary metastases (PMs) are relatively common in patients with colorectal cancer. The m...
Surgery is considered an effective therapeutic option for patients with lung metastasis (MTS) of col...
To assess the impact of a history of liver metastases on survival in patients undergoing surgery for...
Aim: Lung and liver are the most common sites of metastases from colorectal cancer (CRC), and approx...
Background: Resection of hepatic metastases is indicated in selected stage IV colorectal cancer (CRC...
BACKGROUND: Resection of hepatic metastases is indicated in selected stage IV colorectal cancer (CRC...
BACKGROUND: Few patients with lung metastases from colorectal cancer (CRC) are candidates for surgic...
40–50% of patients with colorectal cancer (CRC) will develop liver metastases (CRLM) during the cour...
BACKGROUND:40-50% of patients with colorectal cancer (CRC) will develop liver metastases (CRLM) duri...
BACKGROUND: Data addressing the outcomes and patterns of recurrence after pulmonary metastasectomy (...
Colorectal cancer (CRC) is a frequently occurring disease, yet diagnosed at a local stage in only 40...
Data addressing the outcomes and patterns of recurrence after pulmonary metastasectomy (PM) in patie...
Resection of lung metastases (LM) from colorectal cancer (CRC) is increasingly performed with a cura...
ObjectiveOur objective was to investigate the role of clinicopathologic factors as predictors of out...
BACKGROUND: Resection of lung metastases (LM) from colorectal cancer (CRC) is increasingly performed...
Liver and pulmonary metastases (PMs) are relatively common in patients with colorectal cancer. The m...
Surgery is considered an effective therapeutic option for patients with lung metastasis (MTS) of col...
To assess the impact of a history of liver metastases on survival in patients undergoing surgery for...
Aim: Lung and liver are the most common sites of metastases from colorectal cancer (CRC), and approx...